Chemours vs OLIN
CC and OLN side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CC and OLN compare
Chemours and OLIN are about the same size, with market caps of $2.1B and $2.0B.
Chemours grew revenue faster over the last twelve months (0.07% versus −0.73% for OLIN).
Chemours keeps more of each dollar of sales as profit, with a net margin of −2.6% compared with −3.3% at OLIN.
Both pay dividends: Chemours yields 2.6% and OLIN 4.5%.
OLIN scores higher on the StockData Score (10 against 5 for Chemours), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CC | OLN |
|---|---|---|
| Size and price | ||
| Market cap | $2.1B | $2.0B |
| Share price | $13.72 | $17.89 |
| Change, 1 year | 7.6% | −7.5% |
| Change, 5 years | −56.8% | −70.3% |
| Beta (5Y) | 1.57 | 1.14 |
| Employees | 5,700 | 7,849 |
| StockData Score | ||
| Total score | 5 | 10 (better) |
| Valuation score | 1 | 3 (better) |
| Growth score | 0 | 0 |
| Performance score | 1 (better) | 0 |
| Health score | 1 | 2 (better) |
| Dividend score | 2 | 5 (better) |
| Valuation | ||
| P/S | 0.4× | 0.3× (better) |
| P/B | 13.3× | 1.2× (better) |
| EV/EBITDA | 7.2× (better) | 13.8× |
| P/FCF | 9.8× | 9.2× (better) |
| FCF yield | 10.2% | 10.9% (better) |
| Fair value | – | $37.61 |
| Margin of safety | – | 52.4% |
| Growth | ||
| Revenue growth (TTM) | 0.07% (better) | −0.73% |
| Revenue growth, 5Y average | 3.2% | 3.3% (better) |
| Net income growth (TTM) | – | −531% |
| EPS growth (TTM) | – | −535% |
| Profitability | ||
| Gross margin | 15.2% (better) | 6.7% |
| Operating margin | – | −1.9% |
| Net margin | −2.6% (better) | −3.3% |
| FCF margin | 3.6% (better) | 3.3% |
| Return on equity | −71.8% | −12.2% (better) |
| Return on invested capital | – | −2.2% |
| Financial health | ||
| Debt / equity | 24.73 | 1.75 (better) |
| Net debt / EBITDA | 4.32 (better) | 7.99 |
| Interest coverage | – | −0.7× |
| Current ratio | 1.81 (better) | 1.45 |
| Altman Z-score | 1.42 | 1.55 (better) |
| Piotroski F-score | 4 | 4 |
| Dividends and buybacks | ||
| Dividend yield | 2.6% | 4.5% (better) |
| Years of dividend growth | 0 | – |
| Dividend growth, 5Y average | −12.5% | – |
| Buyback yield | – | 0.50% |
| Shareholder yield | 2.6% | 5.0% (better) |
| Ownership | ||
| Held by institutions | 90.2% | 99.8% |
| Held by insiders | 0.96% | 0.44% |
| Insider net buying, 12 months | $489K (better) | −$2.4M |
| Superinvestors holding | – | 2 |
| Short interest, % of float | 9.8% | 12.2% |
Go deeper
- CC stock overview
- CC income statement
- CC valuation and score
- OLN stock overview
- OLN income statement
- OLN valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.